• NeoGenomics appointed Carolyn Starrett to its board of directors.
• Starrett spent 2016-2026 at Flatiron Health, serving as CEO and board director from April 2021 to September 2025.
• She is president of Starrett Advisory, advising on healthcare delivery, drug development, data, and AI strategy.
• She previously served on Foundation Medicine’s board from 2021 to 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260625576063) on June 25, 2026, and is solely responsible for the information contained therein.